Sort by
Refine Your Search
-
. Our lead candidate includes a small molecule inhibitor targeting the helicase ALC1, an important molecular machine that reorganizes the genome upon DNA damage, which has entered clinical Phase I/II
Enter an email to receive alerts for atomic-physic "https:" positions